TAZloC-Beta 25 Tablet PR

Description

About TAZloC-Beta 25 Tablet PR:
TAZloC-Beta 25 Tablet PR combines Telmisartan and Metoprolol Succinate to provide enhanced blood pressure management.

• Telmisartan (40mg): An angiotensin II receptor blocker (ARB) that relaxes blood vessels and reduces vascular resistance.

• Metoprolol Succinate (25mg): A beta-blocker that slows the heart rate and decreases the heart’s workload.

This combination is ideal for patients with hypertension, particularly those with increased cardiovascular risk, or who require both blood vessel relaxation and heart rate control.

How It Works:

• Telmisartan: Blocks angiotensin II receptors, preventing blood vessel constriction.

• Metoprolol Succinate: Reduces heart rate and cardiac output, lowering blood pressure.

• Together, they provide dual-action antihypertensive therapy for better blood pressure control and cardiovascular protection.

Uses:

• Management of high blood pressure (hypertension)

• Reduces risk of heart attack, stroke, and heart failure

• Suitable for patients needing combined ARB and beta-blocker therapy

Directions for Use:

• Take once daily, preferably at the same time each day, as prescribed by your doctor.

• Swallow the tablet whole with water, preferably with food.

• Follow a healthy lifestyle, balanced diet, and regular exercise to optimize blood pressure control.

Side Effects:
Common side effects may include:

• Dizziness or lightheadedness

• Fatigue

• Slow heart rate (bradycardia)

• Mild gastrointestinal discomfort (nausea, diarrhea)

Seek medical attention if you experience severe dizziness, fainting, swelling, irregular heartbeat, or difficulty breathing.

Precautions:

• Avoid in patients with severe liver or kidney disease, asthma, heart block, or hypotension

• Monitor blood pressure, heart rate, and kidney function regularly

• Not recommended during pregnancy or breastfeeding unless prescribed

• Inform your doctor about other medications, especially other antihypertensives or heart medications